|
Table of Content Volume 15 Issue 3 - September 2020
Spontaneous spinal epidural hematoma in a patient on oral anticoagulant (Dabigatran)
Mustafa Taskeen1*, Dileep Kadam2, Shreyas Wajekar3
1Junior Resident, 2Professor, 3Junior Resident, Department of Medicine, Smt Kashibai Navale Medical College and Research Center, Narhe Ambegaon Pune 411041, INDIA.
Email: drmustafataskeen@gmail.com
REFERENCES
- Kim KT, Cho DC, Ahn SW, Kang SH. Epidural hematoma related with low-dose aspirin: complete recovery without surgical treatment. J Korean Neurosurg Soc 2012;51:308–311.
- Yang SM, Kang SH, Kim KT, Park SW, Lee WS. Spontaneous spinal epidural hematomas associated with acute myocardial infarction treatment. Korean Circ J 2011;41:759–762
- Shin JJ, Kuh SU, Cho YE. Surgical management of spontaneous spinal epidural hematoma. Eur Spine J. 2006;15:998e1004.
- Y. M. Mekaj, A. Y. Mekaj, S. B. Duci, and E. I. Miftari, “New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events,” Therapeutics and Clinical Risk Management, vol. 11, pp. 967–977, 2015.
- J. M. Castillo, H. F. Afanador, E. Manjarrez, and X. A. Morales, “Non-traumatic spontaneous spinal subdural hematoma in a patient with non-valvular atrial fibrillation during treatment with rivaroxaban,” American Journal of Case Reports, vol. 16, pp. 377–381, 2015.
- C. Dargazanli, N. Lonjon, and G. Gras-Combe, “Nontraumatic spinal subdural hematoma complicating direct factor Xa inhibitor treatment (rivaroxaban): a challenging management,” European Spine Journal, vol. 25, no. 1, pp. 1–4, 2016.
- M. Zaarour, S. Hassan, N. Thumallapally, and Q. Dai, “Rivaroxaban-induced nontraumatic spinal subdural hematoma: an uncommon yet life-threatening complication,” Case Reports in Hematology, vol. 2015, Article ID 275380, 5 pages, 2015.
- Pradaxa US Prescribing Information. Ridgefield: Boehringer Ingelheim Pharmaceuticals, Inc; 2015. Available at: http://docs.boehringer-ingelheim.com/Prescribing Information/PIs/Pradaxa/Pradaxa.pdf.
- Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet. 2008; 47:285–295.
- Douxfils J, Mullier F, Robert S, Chatelain C, Chatelain B, Dogne JM. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate. Thromb Haemost. 2012;107:985–997.
- Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al... Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139e51.
- PRADAXA® (dabigatran etexilate mesylate) capsules, for oral use Initial U.S. Approval: 2010 accessed from www.fda.gov/medwatch.
- Binder KD, D Sonne C, Lawton TM. Spinal epidural hematoma. Neurosurg Q. 2004;14:51e59.
- V.B. Moises Heleno, B. Raphael, Conservative treatment of large spontaneous spinal extradural hematoma, Arq. Neuropsiquiatr. 68 (2010) 130–131.
- J. G. Heckmann, “Spinal subarachnoid haemorrhage in cortical superficial siderosis after apixaban and clopidogrel therapy,” Journal of Thrombosis and Thrombolysis, vol. 41, no. 4, pp. 654-655, 2016.
- Hadley MN, Walters BC. Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013;72:1e259.
- P. Gelosa, L. Castiglioni, M. Tenconi et al..., “Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs),” Pharmacological Research, vol. 135, pp. 60–79, 2018.
|
|